Sun Sep 15 11:44:50 UTC 2024: ## Becton, Dickinson and Company (BDX) Sees Increased Institutional Interest:

**New York, NY – September 15, 2024** – Becton, Dickinson and Company (NYSE: BDX), a leading medical supplies and equipment manufacturer, has attracted significant attention from institutional investors in recent quarters. LPL Financial LLC, a prominent institutional investor, increased its stake in BDX by 2.1% during the second quarter, acquiring an additional 5,616 shares. This brings LPL Financial LLC’s total holdings to 275,476 shares, representing approximately 0.10% of BDX’s outstanding stock.

Several other institutional investors have also adjusted their BDX holdings in recent quarters. Norges Bank, a Norwegian sovereign wealth fund, established a new position in BDX during the fourth quarter, with a value of $761,798,000. Similarly, Nordea Investment Management AB significantly increased its stake in BDX by 277.3% in the first quarter, now holding 1,936,654 shares. Other notable investors include PineStone Asset Management Inc. and M&G Plc, who also acquired new positions in BDX during recent periods.

Analysts are also optimistic about BDX’s future prospects. Stifel Nicolaus recently boosted its price objective on BDX shares to $280.00, giving the stock a “buy” rating. Goldman Sachs Group also initiated coverage on BDX, assigning a “buy” rating and a $274.00 price target. The consensus rating among analysts currently stands at “Moderate Buy” with an average target price of $279.50.

In its most recent earnings report on August 1st, BDX reported earnings per share of $3.50, exceeding analysts’ expectations. The company’s revenue also grew by 2.3% year-over-year, indicating positive performance.

BDX’s strong performance, coupled with growing institutional interest and positive analyst sentiment, suggest a bright future for the company.

**Disclaimer:** This article is for informational purposes only and does not constitute financial advice.

Read More